Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease

Journal of Nuclear Medicine

Volumn 43, Issue 1, 2002, Pages 21-26

  Herholz, Karl ^a   Schopphoff, Helge ^a   Schmidt, Mathias ^a   Mielke, Rüdiger ^a   Eschner, Wolfgang ^a   Scheidhauer, Klemens ^a   Schicha, Harald ^a   Heiss, Wolf Dieter ^a   Ebmeier, Klaus ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

18F FDG; 99mTc HMPAO; Alzheimer's disease; PET; SPECT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; INTERMETHOD COMPARISON; MALE; MINI MENTAL STATE EXAMINATION; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036152419     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alzheimer's disease: Focal cortical changes shown by positron emission tomography
2. 18F scan in Alzheimer's disease and multi-infarct dementia
3. Cerebral perfusion imaging in Alzheimer's disease: Use of single photon emission computed tomography and iofetamine hydrochloride I 123
4. SPECT study of regional cerebral blood flow in Alzheimer disease
5. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: Comparison with fluorine-18-FDG PET
6. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: Comparison of perfusion and metabolic pattern
7. Use of automated image registration to generate mean brain SPECT image of Alzheimer's patients
8. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT
9. Tc-99m ethyl cysteinate dimer SPECT and 2-[F-18]fluoro-2-deoxy-D-glucose PET in Alzheimer's disease: Comparison of perfusion and metabolic patterns
10. 18FIFDG PET: A clinical validation of statistical parametric mapping
11. A voxel-based analysis of cerebral perfusion in dementia and depression of old age
12. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: A SPECT study using HMPAO and image standardization technique
13. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT
14. Clinical diagnosis of Alzheimer's disease
15. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician
16. Screening for dementia by memory testing
17. Development of a rating scale for primary depressive illness
18. Pathological verification of ischemia score in differentiation of dementias
19. The ECAT EXACT HR: Performance of a new high resolution positron scanner
20. Comparability of FDG PET studies in probable Alzheimer's disease
21. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET
22. Diagnosing Alzheimer's disease in elderly, mildly demented patients: The impact of routine single photon emission computed tomography
23. FDG PET imaging in patients with pathologically verified dementia
24. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
25. 18F]fluoromethane PET in cerebrovascular disease
26. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man
27. The retention mechanism of technetium-99m-HM-PAO: Intracellular reaction with glutathione
28. Oxido-reductive state: The major determinant for cellular retention of technetium-99m-HMPAO
29. HMPAO as a regional cerebral blood flow tracer at high flow levels
30. Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension: What is the functional link?
31. Altered cerebral energy metabolism in Alzheimer's disease: A PET study
32. Impaired metabolic activation in Alzheimer's disease: A PET study during continuous visual recognition